Ethylenediamine

Ethylenediamine

SCHEMBL2316181

CCCNN(C)C.NCCN

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylenediamine SCHEMBL19859034 1.00 CYP2C9 (0.33) CYP2C9CYP2C19TDP1
SCHEMBL27432894 0.88 ADH1B (0.32)
SCHEMBL30160 0.88
SCHEMBL28297084 0.87 DNM1 (0.48) TDP1
Hydrochloric Acid SCHEMBL28400231 0.85
Ammonia Solution, Strong SCHEMBL4441190 0.85
Fluoride SCHEMBL9160415 0.85
Iodide SCHEMBL28709678 0.85
Ammonia Solution, Strong SCHEMBL8476165 0.85
Hydrogen Sulfide SCHEMBL16226309 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8496716-B2 Method for producing Mannich adducts that contain polyisobutylene phenol BASF SE (DE) 2013-07-30 US disclosed
US-20110251114-A1 METHOD FOR PRODUCING MANNICH ADDUCTS THAT CONTAIN POLYISOBUTYLENE PHENOL BASF SE (DE) 2011-10-13 US disclosed
US-8016898-B1 Method for producing Mannich adducts that contain polyisobutylene phenol BASF AKTIENGESELLSCHAFT (DE) 2011-09-13 US disclosed
US-7988749-B2 Method for producing Mannich adducts that contain polyisobutylene phenol BASF SE (DE) 2011-08-02 US disclosed
US-20080274924-A1 Alkylation of a phenol with polyisobutylene at low temperature in presence of alkylation catalyst; then formaldehyde and amine; oil and fuel additive BASF AKTIENGESELLSCHAFT (DE) 2008-11-06 US disclosed
US-20050268539-A1 Additive mixture for fuel and lubricants BASF AKTIENGESELLSCHAFT (DE) 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110251114-A1 METHOD FOR PRODUCING MANNICH ADDUCTS THAT CONTAIN POLYISOBUTYLENE PHENOL ADH1C, FANCF, PCNA CYP2C9 2347/4885CYP2C19 2247/4885TDP1 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.